Veran Medical Technologies made an announcement today that it has recently finished its first installation of its new product at Duke University Medical Center. Jerome R. Edwards, Veran president and chief executive officer said "Performing these procedures at Duke marks a significant milestone in the company's history,"
The new product is called SPiN Drive™, it enables clinicians to navigate deep into the peripheral areas of the lungs to access, biopsy and treat potentially cancerous Solitary Pulmonary Nodules (SPN's). It acts as a GPS-like system to enable pulmonologists and surgeons to access these SPN's to diagnose malignancy immediately, and reduce the costs added to the healthcare system. Troy L. Holsing, Veran chief technology officer said "We feel confident that our product provides the needed accuracy and streamlined workflow to truly enable pulmonologists to diagnose and treat lung cancer in a manner that makes a significant impact," Momen Wahidi, MD, Director of Interventional Pulmonology and Bronchoscopy at Duke University Medical Center said "I am pleased with how accurate, fast, and easy to use the SPiN Drive system is,"